- Home
- CEV vs OPTN Comparison
CEV vs OPTN Comparison
Compare CEV & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- OPTN
- Stock Information
- Founded
- CEV 1999
- OPTN 2010
- Country
- CEV United States
- OPTN United States
- Employees
- CEV N/A
- OPTN N/A
- Industry
- CEV Finance/Investors Services
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- CEV Finance
- OPTN Health Care
- Exchange
- CEV Nasdaq
- OPTN Nasdaq
- Market Cap
- CEV 71.3M
- OPTN 78.4M
- IPO Year
- CEV N/A
- OPTN 2017
- Fundamental
- Price
- CEV $10.08
- OPTN $6.92
- Analyst Decision
- CEV
- OPTN Strong Buy
- Analyst Count
- CEV 0
- OPTN 3
- Target Price
- CEV N/A
- OPTN $16.67
- AVG Volume (30 Days)
- CEV 19.6K
- OPTN 60.5K
- Earning Date
- CEV 01-01-0001
- OPTN 03-06-2025
- Dividend Yield
- CEV 4.23%
- OPTN N/A
- EPS Growth
- CEV N/A
- OPTN N/A
- EPS
- CEV 0.36
- OPTN N/A
- Revenue
- CEV N/A
- OPTN $75,672,000.00
- Revenue This Year
- CEV N/A
- OPTN $13.42
- Revenue Next Year
- CEV N/A
- OPTN $38.54
- P/E Ratio
- CEV $29.36
- OPTN N/A
- Revenue Growth
- CEV N/A
- OPTN 5.13
- 52 Week Low
- CEV $8.83
- OPTN $4.82
- 52 Week High
- CEV $10.91
- OPTN $31.50
- Technical
- Relative Strength Index (RSI)
- CEV 43.10
- OPTN 55.46
- Support Level
- CEV $9.91
- OPTN $5.16
- Resistance Level
- CEV $10.23
- OPTN $6.97
- Average True Range (ATR)
- CEV 0.06
- OPTN 0.69
- MACD
- CEV 0.01
- OPTN 0.17
- Stochastic Oscillator
- CEV 53.13
- OPTN 83.26
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.